Analysis of Surgery in Patients Presenting With Stage IV Breast Cancer
NCT00941759 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2025-07-16
Summary
The purpose of this study is to study patients presenting with stage IV breast cancer. Stage IV means that the breast cancer has spread to another part of the body outside the breast. This study is important because in different parts of the country some patients are being offered surgical treatment for the breast tumor and some are not. The doctors do not know if surgery for the breast tumor is helpful in patients with stage IV breast cancer. The doctors will collect information about the patient and their treatment to learn more about how patients and doctors make treatment decisions. The doctor will also collect blood samples and tissue samples for laboratory studies to learn more about tumors that have spread to other parts of the body.
Conditions
Sponsors & Collaborators
-
University of Chicago
collaborator OTHER - collaborator OTHER
-
Georgetown University
collaborator OTHER - collaborator OTHER
-
M.D. Anderson Cancer Center
collaborator OTHER -
University of Alabama at Birmingham
collaborator OTHER -
University of California, San Francisco
collaborator OTHER -
University of North Carolina
collaborator OTHER - collaborator OTHER
-
Vanderbilt-Ingram Cancer Center
collaborator OTHER -
Indiana University Melvin and Bren Simon Cancer Center
collaborator OTHER - collaborator OTHER
-
University of Pittsburgh Medical Center
collaborator OTHER - collaborator OTHER
-
Memorial Sloan Kettering Cancer Center
lead OTHER
Principal Investigators
-
Monica Morrow, MD · Memorial Sloan Kettering Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-07-31
- Primary Completion
- 2023-07-10
- Completion
- 2023-07-10
Countries
- United States
Study Locations
More Related Trials
-
Study of Tumor and Blood Samples From Women With Breast Cancer
NCT00897728 ·Status: UNKNOWN
-
Study of the Influence of Ductal Carcinoma in Situ on the Outcome of Invasive Breast Cancer
NCT03669952 ·Status: COMPLETED
-
Post-Treatment Surveillance in Breast Cancer: Bringing CER to the Alliance
NCT02171078 ·Status: COMPLETED
-
Studying Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers
NCT00897455 ·Status: UNKNOWN
-
Long Term Follow-Up in Patients With Stage 0-IIIC Breast Cancer
NCT04661982 ·Status: ACTIVE_NOT_RECRUITING
-
Blood Levels of Tumor Cells in Predicting Response in Patients Receiving First-Line Chemotherapy for Stage IV Breast Cancer
NCT00898014 ·Status: COMPLETED
-
Young Breast Cancer Survivors Study
NCT05981716 ·Status: UNKNOWN
-
Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer
NCT07217990 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Delayed Selective Sentinel Node Biopsy for Patients Undergoing Mastectomy for DCIS
NCT05912569 ·Status: RECRUITING ·Phase: NA
-
A Study to Determine the Clinical Significance of Molecular Detection of Breast Cancer in the Blood of Stage IV Breast Cancer Patients
NCT00355316 ·Status: COMPLETED ·Phase: NA
-
Molecular Analysis of Breast Cancer
NCT00569049 ·Status: COMPLETED
-
Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS)
NCT04797299 ·Status: RECRUITING
-
5 Years Follow-up With Adjuvant Therapy for Women With Breast Invasive Carcinoma
NCT02791750 ·Status: COMPLETED
-
Partial Breast Irradiation for Low-risk Ductal Carcinoma In Situ After Breast-conserving Surgery
NCT02617082 ·Status: UNKNOWN
-
A Multicenter Prospective Observational Cohort Based on a Breast Cancer Medical Record Database in China
NCT06591039 ·Status: RECRUITING
-
Reducing Underuse of Early-Stage Breast Cancer Treatment in Minority Communities
NCT00145197 ·Status: COMPLETED ·Phase: NA
-
Avoiding Low-value Treatments in Older Women With Early-stage Breast Cancer: Piloting a Patient Decision Aid
NCT05140252 ·Status: COMPLETED ·Phase: NA
-
Tracking Triple-negative Breast Cancer Evolution Through Therapy
NCT03077776 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers
NCT00899145 ·Status: WITHDRAWN
-
Pilot Study to Define the Immune Response Following Cryoablation of Invasive Breast Cancer
NCT03523299 ·Status: WITHDRAWN ·Phase: NA
-
HER2-positive Breast Cancer With Brain Metastasis (GCC 1345)
NCT01924351 ·Status: WITHDRAWN ·Phase: PHASE2
-
Diagnostic Procedures in Detecting Tumor Cells in the Bone Marrow of Patients Undergoing Surgery for Stage I, Stage II, or Stage IIIA Breast Cancer
NCT00089323 ·Status: COMPLETED ·Phase: NA
-
Prognostic Value of Biomarkers in HR + / HER2 - Advanced Breast Cancer
NCT04683770 ·Status: UNKNOWN
-
Personalized Second Chance Breast Conservation (PSCBC): A Prospective Phase II Clinical Study
NCT04371913 ·Status: RECRUITING ·Phase: NA
-
Adjuvant Treatment in Premenopausal Breast Cancer
NCT06807749 ·Status: NOT_YET_RECRUITING